These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25301086)

  • 1. Metabolic syndrome and outcomes following early-stage breast cancer.
    Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
    Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
    Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS
    Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
    Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
    Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
    Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from a Long-Term Follow-Up Evaluation of Early Breast Cancer Outcomes by Tumor Subtype.
    Zanardi E; Di Meglio A; Boccardo C; Zinoli L; Salvi S; Rubagotti A
    Oncol Res Treat; 2020; 43(7-8):362-371. PubMed ID: 32512573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
    PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent antibiotic use and second breast cancer events.
    Wirtz HS; Buist DS; Gralow JR; Barlow WE; Gray S; Chubak J; Yu O; Bowles EJ; Fujii M; Boudreau DM
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1588-99. PubMed ID: 23833124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer during follow-up and progression - A population based cohort on new cancers and changed biology.
    Karlsson E; Appelgren J; Solterbeck A; Bergenheim M; Alvariza V; Bergh J
    Eur J Cancer; 2014 Nov; 50(17):2916-24. PubMed ID: 25241230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: A population-based study in British Columbia from 2003 to 2013.
    Le D; Speers C; Thompson L; Gondara L; Nichol A; Lohrisch C
    Cancer; 2020 Mar; 126(5):971-977. PubMed ID: 31750938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
    Cantini L; Pistelli M; Merloni F; Fontana A; Bertolini I; De Angelis C; Bastianelli L; Della Mora A; Santinelli A; Savini A; Maccaroni E; Diodati L; Falcone A; Berardi R
    Clin Breast Cancer; 2020 Feb; 20(1):e89-e98. PubMed ID: 31378534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.
    Mukhtar RA; Moore AP; Tandon VJ; Nseyo O; Twomey P; Adisa CA; Eleweke N; Au A; Baehner FL; Moore DH; McGrath MS; Olopade OI; Gray JW; Campbell MJ; Esserman LJ
    Ann Surg Oncol; 2012 Nov; 19(12):3979-86. PubMed ID: 22622474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of triple negative phenotype on breast cancer prognosis.
    Kaplan HG; Malmgren JA
    Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
    Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A
    Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival.
    Tarhan MO; Demir L; Somali I; Yigit S; Erten C; Alacacioglu A; Ellidokuz H; Seseogullari O; Kucukzeybek Y; Can A; Dirican A; Bayoglu V; Akyol M
    Clin Exp Metastasis; 2013 Feb; 30(2):201-13. PubMed ID: 22915160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
    Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
    J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, mortality and receptor status of breast cancer in African Caribbean women: Data from the cancer registry of Guadeloupe.
    Deloumeaux J; Gaumond S; Bhakkan B; Manip M'Ebobisse N; Lafrance W; Lancelot P; Vacque D; Negesse Y; Diedhiou A; Kadhel P
    Cancer Epidemiol; 2017 Apr; 47():42-47. PubMed ID: 28119121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancer.
    Oudanonh T; Nabi H; Ennour-Idrissi K; Lemieux J; Diorio C
    Int J Cancer; 2020 May; 146(10):2736-2745. PubMed ID: 31403177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
    Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
    JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.